CROs embracing tech to decentralize trials and speed enrollment as regulators show support ‘with their feet’
CROs embracing tech to decentralize trials and speed enrollment as [...]
CROs embracing tech to decentralize trials and speed enrollment as [...]
Fresh from $86M series A, Metis poaches Kala CSO to [...]
Bloodletting at Zymeworks as new CEO axes half of senior [...]
Fierce JPM Week: Confidence is high for Eli Lilly CEO [...]
Fierce JPM Week: As Novartis tries to avoid ‘me-too’ meds [...]
Charles River diving deeper into AI drug development in partnership [...]
Altos bursts out of stealth with $3B, a dream team [...]
Barron quits GSK to take CEO post at $3B biotech [...]
Eli Lilly lines up metabolic pacts with Evotec, Abbisko as [...]
With $825M SPAC merger, ProKidney sets stage for phase 3 [...]